Published in Mol Cell Biochem on September 01, 2004
Novel mechanism for obesity-induced colon cancer progression. Carcinogenesis (2009) 1.17
Productive dengue virus infection of human endothelial cells is directed by heparan sulfate-containing proteoglycan receptors. J Virol (2011) 1.15
Interstitial fluid flow intensity modulates endothelial sprouting in restricted Src-activated cell clusters during capillary morphogenesis. Tissue Eng Part A (2009) 1.14
Src homology 2 (SH2) domain containing protein tyrosine phosphatase-1 (SHP-1) dephosphorylates VEGF Receptor-2 and attenuates endothelial DNA synthesis, but not migration*. J Mol Signal (2008) 1.11
Dopamine regulates phosphorylation of VEGF receptor 2 by engaging Src-homology-2-domain-containing protein tyrosine phosphatase 2. J Cell Sci (2009) 0.91
Endogenous vascular endothelial growth factor-A (VEGF-A) maintains endothelial cell homeostasis by regulating VEGF receptor-2 transcription. J Biol Chem (2011) 0.89
POEMS Syndrome: A Report of 14 Cases and Review of the Literature. ISRN Gastroenterol (2012) 0.87
Hepatocyte growth factor inhibits VEGF-forkhead-dependent gene expression in endothelial cells. Arterioscler Thromb Vasc Biol (2008) 0.84
Expression of angiostatin cDNA in human gallbladder carcinoma cell line GBC-SD and its effect on endothelial proliferation and growth. World J Gastroenterol (2006) 0.78
Determination of VEGFR-2 (KDR) 604A>G Polymorphism in Pancreatic Disorders. Int J Mol Sci (2017) 0.75
Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis (2008) 2.99
Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. Cancer Res (2008) 2.20
Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis. Proc Natl Acad Sci U S A (2010) 1.95
Neuropilin-1-mediated vascular permeability factor/vascular endothelial growth factor-dependent endothelial cell migration. J Biol Chem (2003) 1.82
Antiangiogenic properties of gold nanoparticles. Clin Cancer Res (2005) 1.78
Effect of nanoparticle surface charge at the plasma membrane and beyond. Nano Lett (2010) 1.77
Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells. J Nanobiotechnology (2008) 1.56
Endothelial cell-specific chemotaxis receptor (ecscr) promotes angioblast migration during vasculogenesis and enhances VEGF receptor sensitivity. Blood (2010) 1.55
Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future. Chem Soc Rev (2012) 1.55
The cytosolic entry of diphtheria toxin catalytic domain requires a host cell cytosolic translocation factor complex. J Cell Biol (2003) 1.55
Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. Adv Drug Deliv Rev (2009) 1.54
Modulating pharmacokinetics, tumor uptake and biodistribution by engineered nanoparticles. PLoS One (2011) 1.53
Revealing the role of phospholipase Cβ3 in the regulation of VEGF-induced vascular permeability. Blood (2012) 1.51
Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis. J Nanobiotechnology (2007) 1.37
Gold nanoparticles: opportunities and challenges in nanomedicine. Expert Opin Drug Deliv (2010) 1.32
Regulation of vascular endothelial growth factor receptor 2 trafficking and angiogenesis by Golgi localized t-SNARE syntaxin 6. Blood (2010) 1.21
Orphan nuclear transcription factor TR3/Nur77 regulates microvessel permeability by targeting endothelial nitric oxide synthase and destabilizing endothelial junctions. Proc Natl Acad Sci U S A (2011) 1.11
Expression and regulatory role of GAIP-interacting protein GIPC in pancreatic adenocarcinoma. Cancer Res (2006) 1.11
Down syndrome candidate region 1 isoform 1 mediates angiogenesis through the calcineurin-NFAT pathway. Mol Cancer Res (2006) 1.11
Inorganic nanoparticles in cancer therapy. Pharm Res (2010) 1.11
Cystathionine beta-synthase (CBS) contributes to advanced ovarian cancer progression and drug resistance. PLoS One (2013) 1.10
Requirement of protein kinase D tyrosine phosphorylation for VEGF-A165-induced angiogenesis through its interaction and regulation of phospholipase Cgamma phosphorylation. J Biol Chem (2006) 1.09
Neurotensin stimulates IL-8 expression in human colonic epithelial cells through Rho GTPase-mediated NF-kappa B pathways. Am J Physiol Cell Physiol (2003) 1.07
Substance P-stimulated interleukin-8 expression in human colonic epithelial cells involves Rho family small GTPases. Biochem J (2002) 1.07
Response gene to complement 32, a novel hypoxia-regulated angiogenic inhibitor. Circulation (2009) 1.05
Sclerostin binds and regulates the activity of cysteine-rich protein 61. Biochem Biophys Res Commun (2009) 1.05
Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge. Nanomedicine (2011) 1.02
Enhancing chemotherapy response with Bmi-1 silencing in ovarian cancer. PLoS One (2011) 1.01
Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle. Proc Natl Acad Sci U S A (2013) 1.01
Metalloproteinase-dependent transforming growth factor-alpha release mediates neurotensin-stimulated MAP kinase activation in human colonic epithelial cells. J Biol Chem (2004) 1.00
VEGF stimulates PKD-mediated CREB-dependent orphan nuclear receptor Nurr1 expression: role in VEGF-induced angiogenesis. Int J Cancer (2010) 0.99
Insulin-like growth factor-1 receptor transactivation modulates the inflammatory and proliferative responses of neurotensin in human colonic epithelial cells. J Biol Chem (2011) 0.98
Protein kinase C zeta transactivates hypoxia-inducible factor alpha by promoting its association with p300 in renal cancer. Cancer Res (2004) 0.97
Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo. PLoS One (2011) 0.96
Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo. Int J Cancer (2012) 0.95
Identifying new therapeutic targets via modulation of protein corona formation by engineered nanoparticles. PLoS One (2012) 0.95
Neurotensin stimulates interleukin-8 expression through modulation of I kappa B alpha phosphorylation and p65 transcriptional activity: involvement of protein kinase C alpha. Mol Pharmacol (2005) 0.94
The vascular permeabilizing factors histamine and serotonin induce angiogenesis through TR3/Nur77 and subsequently truncate it through thrombospondin-1. Blood (2013) 0.93
Neurotensin stimulates expression of early growth response gene-1 and EGF receptor through MAP kinase activation in human colonic epithelial cells. Int J Cancer (2007) 0.93
Ghrelin stimulates interleukin-8 gene expression through protein kinase C-mediated NF-kappaB pathway in human colonic epithelial cells. J Cell Biochem (2006) 0.92
Dopamine regulates phosphorylation of VEGF receptor 2 by engaging Src-homology-2-domain-containing protein tyrosine phosphatase 2. J Cell Sci (2009) 0.91
Fabrication and functional characterization of goldnanoconjugates for potential application in ovarian cancer. J Mater Chem (2010) 0.90
Protein-mediated autoreduction of gold salts to gold nanoparticles. Biomed Mater (2008) 0.87
Efficient delivery of gold nanoparticles by dual receptor targeting. Adv Mater (2011) 0.86
Cancer nanotechnology: emerging role of gold nanoconjugates. Anticancer Agents Med Chem (2011) 0.84
Gold Nanoparticle Reprograms Pancreatic Tumor Microenvironment and Inhibits Tumor Growth. ACS Nano (2016) 0.83
Lanthanide phosphate nanorods as inorganic fluorescent labels in cell biology research. Clin Chem (2007) 0.83
Switching the targeting pathways of a therapeutic antibody by nanodesign. Angew Chem Int Ed Engl (2011) 0.82
Angiopoietin-1 and vascular endothelial growth factor regulation of leukocyte adhesion to endothelial cells: role of nuclear receptor-77. Arterioscler Thromb Vasc Biol (2012) 0.81
Probiotic yeast inhibits VEGFR signaling and angiogenesis in intestinal inflammation. PLoS One (2013) 0.81
Probing novel roles of the mitochondrial uniporter in ovarian cancer cells using nanoparticles. J Biol Chem (2013) 0.80
Inhibiting the growth of pancreatic adenocarcinoma in vitro and in vivo through targeted treatment with designer gold nanotherapeutics. PLoS One (2013) 0.80
Inorganic phosphate nanorods are a novel fluorescent label in cell biology. J Nanobiotechnology (2006) 0.80
Understanding protein-nanoparticle interaction: a new gateway to disease therapeutics. Bioconjug Chem (2014) 0.80
Transcription enhancer factor 3 (TEF3) mediates the expression of Down syndrome candidate region 1 isoform 1 (DSCR1-1L) in endothelial cells. J Biol Chem (2008) 0.79
A simple synthesis of a targeted drug delivery system with enhanced cytotoxicity. Chem Commun (Camb) (2011) 0.75
A core-shell nanomaterial with endogenous therapeutic and diagnostic functions. Cancer Nanotechnol (2010) 0.75